Albany International (AIN) Stock And The Value Question After Progress In Enzyme Textile Recycling
Albany International Corp. Class A AIN | 0.00 |
Albany International (AIN) is back in focus after reporting further progress in its collaboration with Sweden based Cyclezyme AB on enzyme based recycling of polyester and polyamide industrial textiles.
The recent Cyclezyme update arrives after a strong run in Albany International’s share price, with a 30 day share price return of 16.98% and a 90 day share price return of 31.17%. However, the 1 year total shareholder return of 7.65% contrasts with declines over the 3 and 5 year periods, suggesting shorter term momentum has picked up even though longer term holders have seen weaker results.
If this kind of materials and industrial technology story interests you, it could be worth broadening your search and checking out 20 top founder-led companies
So with Albany International up 31.17% over 90 days, but longer term returns still soft and the stock trading above its analyst target, are you looking at a fresh buying opportunity or a market that has already priced in the company’s prospects?
Most Popular Narrative: 25.2% Overvalued
The most widely followed narrative puts Albany International’s fair value at $56.67, noticeably below the last close at $70.95, which raises questions about how much optimism is already in the price.
Accelerating adoption of lightweight composites in aerospace and defense, demonstrated by expanding content on next-gen aircraft, ramping on key programs like CH-53K, LEAP, and Bell 525, and new applications such as 3D woven parts replacing titanium, positions Albany's Engineered Composites segment for significant high-margin revenue and earnings expansion.
Want to see what revenue mix, margin lift, and future earnings power are baked into that fair value? The narrative rests on aggressive profitability shifts and a very specific path for growth and capital returns.
Result: Fair Value of $56.67 (OVERVALUED)
However, execution setbacks in new aerospace programs, or a deeper decline in traditional paper related demand, could quickly challenge the optimistic profitability and valuation narrative around Albany International.
Another Angle On Value: Sales Multiple Vs Fair Ratio
While analysts see Albany International as 25.2% overvalued at $70.95 versus their $56.67 fair value, the price tag looks different when you focus on sales. The current P/S sits around 1.7x, compared with 2.1x for the US Machinery industry and 2.6x for peers, but above an estimated fair ratio of 1x. This suggests the market could shift closer to that lower anchor over time. With the stock also trading above the SWS estimate of future cash flow value at $38.81, investors may be weighing whether this represents a premium that persists or one that eventually narrows.
For a closer look at how those cash flow assumptions work in practice, take a look at the SWS DCF model, starting with Look into how the SWS DCF model arrives at its fair value.
Next Steps
If this mix of optimism and concern around Albany International feels familiar, it is a good moment to move quickly and test the numbers yourself, then weigh the 1 key reward and 2 important warning signs.
Ready to scout your next investment ideas?
If Albany International is on your radar, do not stop here. Use the Simply Wall Street Screener to quickly spot fresh ideas that fit your approach.
- Target potential mispricings by scanning companies that combine quality with attractive valuations using the 44 high quality undervalued stocks.
- Prioritize strength by focusing on businesses with robust finances and reliable fundamentals through the solid balance sheet and fundamentals stocks screener (48 results).
- Get ahead of the crowd by filtering for underfollowed opportunities with the screener containing 20 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
